Supplemental Files of article: Drug repurposing in cancer and Cushing's disease: halogenated salicylanilides inhibit USP8 catalytic activity and ACTH release by pituitary cells

Supplemental Files related to Thierry Waltrich-Augusto, Magda Mortier and Caroline Barette et al. Drug Repurposing in Cancer and Cushing’s Disease: Halogenated Salicylanilides Inhibit USP8 Catalytic Activity and ACTH Release by Pituitary Cells. DrugRepo. 2026. Vol. 2(2). DOI: 10.58647/DRUGREPO.25.1.0007 Authors: Thierry WALTRICH-AUGUSTO (1,2), Magda MORTIER (1), Caroline BARETTE (1), Emmanuelle SOLEILHAC (1), Laurence AUBRY (3) and Marie-Odile FAUVARQUE (1) * (1) Univ. Grenoble Alpes, CEA, Inserm, IRIG, BGE UA13, F-38000 Grenoble, France) (2) Present address: Wessex Investigational Sciences Hub, University of Southampton, Southampton UK-SO16 6YD (3) Univ. Grenoble Alpes, CNRS, CEA, Inserm, IRIG, BGE UA13, F-38000 Grenoble, France * Author for correspondence